Increased production of nitric oxide stimulated by interleukin-1β in peripheral blood mononuclear cells in patients with systemic sclerosis

British Journal of Rheumatology

Volumn 37, Issue 10, 1998, Pages 1123-1125

  Yamamoto, T ^a   Sawada, Y ^a   Katayama, I ^a   Nishioka, K ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Cytokine; Nitric oxide; Systemic sclerosis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

ADULT; CELLS, CULTURED; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; NITRIC OXIDE; SCLERODERMA, SYSTEMIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031754714     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
2. Vladutiu AO. Role of nitric oxide in autoimmunity. Clin Immunol Immunopathol 1995;76:1-11.
3. Cook HT, Cattell V. Role of nitric oxide in immune-mediated diseases. Clin Sci 1996;91:375-84.
4. Yamamoto T, Katayama I, Nishioka K. Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis. J Rheumatol 1998;25:314-7.
5. American Rheumatism Association. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
6. Barnett AJ, Miller MH, Littlejohn GO. A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): The value of a simple cutaneous classification in the early stages of the disease. J Rheumatol 1988;15:276-83.
7. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
8. Schmidt HH, Walter U. NO at work. Cell 1994;78:918-25.
9. Sakurai H, Kohsaka H, Liu M-F et al. Nitric oxide production and inducible nitric oxide synthesis expression in inflammatory arthritides. J Clin Invest 1995;96:2357-63.
10. Grabowski PS, England A, Dykhuizen R et al. Elevated nitric oxide production in rheumatoid arthritis. Arthritis Rheum 1996;39:642-7.
11. Kontitinen YT, Platts LAM, Touminen S et al. Role of nitric oxide in Sjögren's syndrome. Arthritis Rheum 1997;40:875-83.
12. Seibold JS. Critical tissue ischemia in scleroderma: a note of caution. Ann Rheum Dis 1994;53:289-90.
13. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physical messenger. Ann Intern Med 1994;120:227-37.
14. Nathan C, Xie Q-W. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994;269:13725-8.
15. Westacott CI, Whicher JT, Hutton CW, Dieppe PA. Increased spontaneous production of interleukin-1 together with inhibitory activity in systemic sclerosis. Clin Sci 1988;75:561-7.
16. Umehara H, Kumagai S, Murakami M et al. Enhanced production of interleukin-1 and tumor necrosis factor by cultured peripheral blood monocytes from patients with scleroderma. Arthritis Rheum 1984;27:645-53.
17. Scott-Burden T, Schini VB, Elizondo E, Junquero DC, Vanhoutte PM. Platelet derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation. Circ Res 1992;71:1088-100.
18. Schini VB, Durante W, Elizondo E et al. The induction of nitric oxide synthase activity is inhibited by TGF-beta 1, PDGFAB and PDGFBB in vascular smooth muscle cells. Eur J Pharmacol 1992;216:379-83.
19. Pfeilschifter J, Vosbeck K. Transforming growth factor beta 2 inhibits interleukin 1 beta- and tumor necrosis factor alpha-induction of nitric oxide synthase in rat renal mesangial cells. Biochem Biophys Res Commun 1991;175:372-9.
20. Junquero DC, Scott-Burden T, Schini VB, Vanhoutte PM. Inhibition of cytokine-induced nitric oxide production by transforming growth factor-beta 1 in human smooth muscle cells. J Physiol 1992;454:451-65.
21. Vodovotz Y, Bogdan C, Paik J, Xie Q, Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β. J Exp Med 1993;178:605-13.
22. Nussler AK, Billiar TR. Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukocyte Biol 1993;54:171-8.
23. Schaffer MR, Tantry U, Gross SS, Wasserkrug HL, Barbul A. Nitric oxide regulates wound healing. J Surg Res 1996;63:237-40.
24. Schaffer MR, Efron PA, Thornton FJ, Klingel K, Gross SS, Barbul A. Nitric oxide, an autocrine regulator of wound fibroblast synthetic function. J Immunol 1997;158:2375-81.